Method of Determining Sensitivity of Human Or Non-human Animal Cells to an IAP Antagonist

cFLIP serves as a biomarker for efficacy of treatment with IAP antagonists, including Smac peptidomimetics.

Patents:
WO 2,010,086,722 [MORE INFO]

Inventor(s): LEVERKUS MARTIN [DE]; GESERICK PETER [DE]; HUPE MICHAEL [DE]

Type of Offer: Sale